Wilhoit Scott L. 4
4 · Strongbridge Biopharma plc · Filed Jan 8, 2021
Insider Transaction Report
Form 4
Wilhoit Scott L.
Chief Commercial Officer
Transactions
- Award
Ordinary Shares
2021-01-07+113,000→ 144,146 total
Footnotes (1)
- [F1]Represents a grant of restricted stock units, which vest in full on January 7, 2023, provided the Reporting Person is employed by the Issuer on such date. Each restricted stock unit represents a contingent right to receive one ordinary share of the Issuer.